IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 316 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $253,000 | +11.9% | 5,305 | +38.5% | 0.09% | -46.0% |
Q2 2020 | $226,000 | -2.2% | 3,830 | 0.0% | 0.17% | +9.4% |
Q4 2019 | $231,000 | +0.9% | 3,830 | 0.0% | 0.16% | -4.8% |
Q3 2019 | $229,000 | -6.9% | 3,830 | 0.0% | 0.17% | -6.7% |
Q2 2019 | $246,000 | -20.9% | 3,830 | 0.0% | 0.18% | -20.1% |
Q1 2019 | $311,000 | +8.0% | 3,830 | -28.1% | 0.22% | -0.4% |
Q4 2018 | $288,000 | +4.7% | 5,330 | 0.0% | 0.22% | +23.0% |
Q3 2018 | $275,000 | +23.9% | 5,330 | 0.0% | 0.18% | +15.1% |
Q2 2018 | $222,000 | -5.5% | 5,330 | 0.0% | 0.16% | -9.7% |
Q1 2018 | $235,000 | -12.3% | 5,330 | 0.0% | 0.18% | -3.8% |
Q4 2017 | $268,000 | -0.7% | 5,330 | 0.0% | 0.18% | -3.2% |
Q3 2017 | $270,000 | -0.4% | 5,330 | 0.0% | 0.19% | -4.1% |
Q2 2017 | $271,000 | +26.6% | 5,330 | 0.0% | 0.20% | +24.7% |
Q1 2017 | $214,000 | -16.1% | 5,330 | 0.0% | 0.16% | -17.7% |
Q4 2016 | $255,000 | -99.9% | 5,330 | +3.9% | 0.19% | +35.2% |
Q1 2016 | $207,765,000 | -49.7% | 5,130 | -23.0% | 0.14% | -48.7% |
Q4 2015 | $412,763,000 | – | 6,665 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |